Walker JL

No ORCID on file · 5 papers in corpus
rct 2019
The New England journal of medicine ·doi:10.1056/nejmoa1902626

BACKGROUND: Secondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation. …

nonrandomized-trial 2018
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.05.029

OBJECTIVES: To determine the efficacy and tolerability of sunitinib in recurrent or persistent clear cell ovarian cancer patients. METHODS: All patients had one or two prior regimens with measurable disease. Tumors were at least 50% clear …

rct 2016
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.10.016

OBJECTIVES: We sought to analyze the clinicopathologic features, recurrence patterns and survival outcomes of women with high-grade uterine cancer (UC) enrolled on The Gynecologic Oncology Group (GOG) LAP2 trial. METHODS: This is a post-ho…

nonrandomized-trial 2014
Journal of Clinical Oncology ·doi:10.1200/jco.2013.54.1987

PURPOSE: Risk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surg…

case-report 1990
Obstetrics and gynecology

Pelvic endometriosis often presents as nodularity of the uterosacral and broad ligaments. Therefore, the presence of unrecognized pelvic endometriosis in cervical cancer patients can masquerade as parametrial spread of tumor, preventing cor…